Related Articles
LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine‑dependent breast cancer: A report of two cases
Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial
Anthracycline‑based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5‑fluorouracil and radiation therapy in surgically resected axillary node‑positive breast cancer
Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy